JPMorgan Downgrades Pfizer (PFE) to Neutral
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.80 +1.86%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JPMorgan analyst Chris Schott downgraded Pfizer (NYSE: PFE) from Overweight to Neutral with a price target of $46.00.
The analyst cites the valuation for the downgrade following a "strong 2018."
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $43.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- Goldman Sachs Positive on SanDisk (SNDK): 'We expect the stock to hold its gains'
- Wolfe Research Downgrades Stryker (SYK) to Peerperform
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
